Roivant Sciences's market cap is currently ―. The company's EPS TTM is $5.21; its P/E ratio is 1.99; Roivant Sciences is scheduled to report earnings on June 26, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 37.14M	$ 37.10M	$ 16.66M	-	$ 17.05M
Gross Profit	$ 37.14M	$ 37.10M	$ 21.62M	-	$ -45.31M
EBIT	$ 5.11B	$ -318.11M	$ -317.18M	-	$ -400.77M
EBITDA	$ 5.11B	$ -310.83M	$ -309.72M	-	$ -393.81M
Net Income Common Stockholders	$ 5.10B	$ -262.66M	$ -291.82M	-	$ -352.01M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 6.67B	$ 1.41B	$ 1.43B	$ 1.68B	$ 1.53B
Total Assets	$ 7.31B	$ 2.07B	$ 2.14B	$ 2.39B	$ 2.20B
Total Debt	$ 506.58M	$ 497.98M	$ 492.63M	$ 481.40M	$ 479.64M
Net Debt	$ -6.16B	$ -910.25M	$ -941.46M	$ -1.20B	$ -1.05B
Total Liabilities	$ 728.10M	$ 739.91M	$ 802.51M	$ 782.02M	$ 775.82M
Stockholders Equity	$ 6.09B	$ 948.53M	$ 910.73M	$ 1.16B	$ 955.52M
Cash Flow	-
Free Cash Flow	$ -210.81M	$ -196.75M	$ -250.29M	-	$ -223.10M
Operating Cash Flow	$ -210.45M	$ -196.47M	$ -249.89M	-	$ -222.59M
Investing Cash Flow	$ 5.23B	$ -36.45M	$ 105.00K	-	$ -3.51M
Financing Cash Flow	$ 236.64M	$ 207.87M	$ 7.48M	-	$ 154.50M

Currency in USD

Roivant Sciences Earnings and Revenue History

Income Statement >

Roivant Sciences Debt to Assets

Balance Sheet >

Roivant Sciences Cash Flow

Cash Flow >

Roivant Sciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing